Resysnthesis of therapeutic agents for treatment of infectious diseases
Ended Definitive Contract Awarded Last action
- Contract number
- 00266200002D266005402
- Awardee
-
Starks Associates Inc. UEI DAY5FJMYL4L8
- Awarding agency
-
NIAID DEA OA Acquisitions
National Institutes of Health, Department of Health and Human Services
- Obligated
- $6,600,929
Award facts
- Contract value 43% obligated
-
- $13,704,190.93 Current, with exercised options
- $15,287,463.93 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- Not on record
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition · 2 offers
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Buffalo, NY 14213, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$54,622 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $990,546 | |
| Funding Only Action | $1,537,186 | |
| Funding Only Action | $1,492,443 | |
| Supplemental Agreement for work within scope | $916,373 | |
| Supplemental Agreement for work within scope | $449,003 | |
| Supplemental Agreement for work within scope | $436,000 | |
| Supplemental Agreement for work within scope | $423,000 | |
| Original award | $411,000 |
About this award
This is a federal contract award to Starks Associates Inc., a for-profit subchapter S corporation, by the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health (NIH). The contract, valued at $15,287,463.93, is for the resynthesis of therapeutic agents for the treatment of infectious diseases. The contract is a definitive contract with a cost-plus-fixed-fee pricing type and has a completion date of September 15, 2011. The contract is set aside for small businesses. Starks Associates provides preclinical services for HIV therapeutics research, including synthesis and acquisition of compounds for biological testing in support of NIAID's HIV drug development efforts. This award is a delivery order under a larger indefinite-delivery/indefinite-quantity (IDIQ) contract with NIAID for Preclinical Services for HIV Therapeutics, which has a ceiling value of $107,274,471 and extends through October 2027. The IDIQ contract allows NIAID to efficiently access Starks Associates' specialized preclinical research capabilities over an extended period.
Quick answers
Who was awarded contract 00266200002D266005402?
00266200002D266005402 was awarded to Starks Associates Inc. by NIAID DEA OA Acquisitions (National Institutes of Health) on February 15, 2000.
How much is contract 00266200002D266005402 worth?
The government has obligated $6,600,929 on 00266200002D266005402. Its current value, with exercised options, is $13,704,191. Its potential value, with all options, is $15,287,464.
Was contract 00266200002D266005402 competed?
The extent of competition for 00266200002D266005402 was full and open competition. The government received 2 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award